By contrast, after silencing GAS5 expression, we found that the inhibitory effects of corylin on HCC cells were attenuated (Figure 6A–E), demonstrating that the anti-HCC mechanisms of corylin are mediated by its upregulation of GAS5. The gene discussed is GAS5; the disease is hepatocellular carcinoma.